‘Kyprolis’ receives health insurance benefits with RSA from 5 February

Published: 2018-02-02 14:31:43

Updated: 2018-02-02 14:31:43

‘Kyprolis Inj,’ an Amgen’s multiple myeloma therapy, has passed the Health Insurance Policy Deliberation Committee

Along with enforcement of the life-prolonging treatment, the government will also carry out other plans, such as a demo project for health insurance benefits and revise of health insurance benefits to provide better psychiatric therapies.

The Ministry of Health and Welfare held t...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.